Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

COPD (Chronic Obstructive Pulmonary Disease) Clinical Trials

A listing of COPD (Chronic Obstructive Pulmonary Disease) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (554) clinical trials

The purpose of the study is to determine if a study medication helps patients with chronic obstructive pulmonary disease (COPD) with emphysema. There will be 7 study visits. Visits will take about 2 hours. There will be a physical exam, vital signs, urine test, blood draw, breathing tests, questionnaires, and ...

Phase N/A

The primary purpose of this study is to demonstrate improvements in lung function for subjects treated with UMEC/VI compared with UMEC for 24 weeks. The effect of UMC/VI, UMEC, and salmeterol with respect to patient HRQoL measured through patient reported outcomes (PROs) Questionnaires, symptoms and lung function will also be ...

Phase

24 week study to assess the efficacy and safety of Glycopyrronium/Formoterol Fumarate (GFF) fixed-dose combination 7.2/4.8 µg 2 inhalations twice daily compared to Umeclidinium/Vilanterol (UV) 62.5/25 µg fixed-dose combination 1 inhalation once daily in patients 40-95 years of age, with moderate to very severe COPD.

Phase N/A

Qualified participants will receive at no cost to them: study medications study-related labs physicals and exams compensation for your time and travel for each visit

Phase N/A

COPD-chronic obstructive pulmonary disease

Phase N/A

Clinical research trial for people with moderate to severe COPD (Chronic Pulmonary Disease)

Phase N/A

An observational study on patients with a diagnosis or suspected diagnosis of asthma and/or COPD to describe patient characteristics, treatment patterns and the burden of illness over time.

Phase N/A

A study to assess the efficacy and safety of PT010 relative to PT003 and PT009 on COPD exacerbations over a 52 week treatment period in subjects with moderate to very severe COPD. Phase III

Phase

This study is comparing a fixed-dose Triple combination product to a fixed-dose dual combination product. The study is for a 12-week duration. We are also including an option for a 24-hour Holter Monitoring as a sub-study to the main study.

Phase

This study is basically comparing two products that are already on the market for patients with COPD, which includes chronic bronchitis and emphysema. The study lasts for approximately 6 months and compensation is provided for your time and travel.

Phase